JR
Julie Rubinstein sold $948K of ADPT stock
Julie Rubinstein, President and COO of Adaptive Biotechnologies Corp (ADPT), sold 35,643 shares of ADPT stock worth $948K, per an SEC Form 4 filed Oct 8, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade happened on Oct 6, 2026, 2 days before it was made public.
ADPT has moved +5.8% since the trade date, from $26.90 to $28.46 (Nov 18, 2026 close).
- Traded
- Oct 6, 2026
- Disclosed
- Oct 8, 2026
- Filing delay
- 2 days
- Price since
- +5.8%
- Role
- President and COO
- Source
- SEC Form 4